Pulmonary artery denervation for pulmonary arterial hypertension: a sham-controlled randomized trial.

Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomized Trial – JACC: Cardiovascular Interventions

Commentaries:

Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test – TCTMD

Pulmonary Artery Denervation for Pulmonary Arterial Hypertension – PADN-CFDA – American College of Cardiology

Commentary on Twitter

#TCT2022 #JACCINT LBCT SimPub: PADN-CFDA trial included 128 pts w/ #cvPAH. At 6-month follow-up, PADN assoc. w/ a ⬆️ improvement in 6MWD, PVR, RV function, & ⬇️ NT-proBNP. Clinical worsening was ⬇️ & satisfactory clinical response was ⬆️ in the PADN group. https://t.co/3IVaUwCgOT pic.twitter.com/bylhcA4GrQ

— JACC Journals (@JACCJournals) September 18, 2022